Paper39725831
Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer.
Campanharo CV and 21 others. Clin Transl Oncol, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer. Papers, record 39725831. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39725831
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Genomics | Major topic |
| Humans | |
| Prognosis | |
| Tumor Microenvironment | |
| Biomarkers, Tumor | |
| Proteomics | |
| Multiomics |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37220590 | Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37220590 | PubMed |
| 2 | 33497432 | Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/33497432 | PubMed |
| 3 | 34439277 | Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439277 | PubMed |
| 4 | 33801837 | Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33801837 | PubMed |
| 5 | 34238766 | Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes. | Mol Cells | 2021 | https://conductscience.org/library/papers/34238766 | PubMed |
| 6 | 33822890 | DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/33822890 | PubMed |
| 7 | 36163046 | Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/36163046 | PubMed |
| 8 | 35959452 | Pan-cancer Landscape of the RUNX Protein Family Reveals their Potential as Carcinogenic Biomarkers and the Mechanisms Underlying their Action. | J Transl Int Med | 2022 | https://conductscience.org/library/papers/35959452 | PubMed |
| 9 | 31068700 | Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | https://conductscience.org/library/papers/31068700 | PubMed |
| 10 | 35416406 | Pan-cancer analysis of mutations in open chromatin regions and their possible association with cancer pathogenesis. | Cancer Med | 2022 | https://conductscience.org/library/papers/35416406 | PubMed |
| 11 | 31561483 | The Need for Multi-Omics Biomarker Signatures in Precision Medicine. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31561483 | PubMed |
| 12 | 32259264 | Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/32259264 | PubMed |
| 13 | 34721325 | Metagenomic and Metatranscriptomic Insight Into Oral Biofilms in Periodontitis and Related Systemic Diseases. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34721325 | PubMed |
| 14 | 34675941 | A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers. | Front Immunol | 2021 | https://conductscience.org/library/papers/34675941 | PubMed |
| 15 | 34446793 | Identification of key proteins in the signaling crossroads between wound healing and cancer hallmark phenotypes. | Sci Rep | 2021 | https://conductscience.org/library/papers/34446793 | PubMed |
| 16 | 33266472 | Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33266472 | PubMed |
| 17 | 33050637 | Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33050637 | PubMed |
| 18 | 33737557 | Integrated multi-omics analysis of ovarian cancer using variational autoencoders. | Sci Rep | 2021 | https://conductscience.org/library/papers/33737557 | PubMed |
| 19 | 34030708 | Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets. | J Transl Med | 2021 | https://conductscience.org/library/papers/34030708 | PubMed |
| 20 | 35945523 | Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35945523 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42406192 | Dissecting PANoptosis in the Nervous System: A Unified Cell-Death Mechanism Driving Neuroimmune Activation and Chronic Neuroinflammation. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42406192 | PubMed |
| 42289048 | Decoding disease and therapy through multiomics integration and systems analysis. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42289048 | PubMed |
| 42125447 | Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes. | NAR Genom Bioinform | 2026 | https://conductscience.org/library/papers/42125447 | PubMed |
| 41726366 | Enhancing the accuracy of molecular classification of pediatric CNS tumors: a dual-classifier approach using DNA methylation profiling. | Front Oncol | 2025 | https://conductscience.org/library/papers/41726366 | PubMed |
| 41463532 | Promoter Hypomethylation Unleashes HMGA1 to Orchestrate Immune Evasion and Therapy Resistance Across Cancers. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41463532 | PubMed |
| 41170373 | Targeting MDM2, RAS, and PCNA for cancer targeted therapy: pan-cancer approaches vs. cancer-specific strategies. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41170373 | PubMed |
| 41133620 | In Search of Ideal Solutions for Cancer Diagnosis: From Conventional Methods to Protein Biomarkers in Liquid Biopsy. | Proteomes | 2025 | https://conductscience.org/library/papers/41133620 | PubMed |
| 40823070 | Cancer complexity: why we need a novel cancer research strategy. | Front Oncol | 2025 | https://conductscience.org/library/papers/40823070 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39725831
GET https://conductscience.org/api/papers/v1/39725831/authors?page=2